217 related articles for article (PubMed ID: 15722243)
1. Prolonged pH monitoring: Bravo capsule.
Pandolfino JE; Kahrilas PJ
Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):307-18. PubMed ID: 15722243
[TBL] [Abstract][Full Text] [Related]
2. Ambulatory esophageal pH monitoring by using a wireless system: a pilot study in Taiwan.
Tu CH; Lee YC; Wang HP; Wu MS; Chiu HM; Lin JT
Hepatogastroenterology; 2004; 51(60):1586-9. PubMed ID: 15532783
[TBL] [Abstract][Full Text] [Related]
3. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
Hirano I
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
[TBL] [Abstract][Full Text] [Related]
4. Catheter-based pH monitoring: use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy).
DeVault KR
Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):289-306. PubMed ID: 15722242
[TBL] [Abstract][Full Text] [Related]
5. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
6. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
7. The Bravo pH capsule system.
Kwiatek MA; Pandolfino JE
Dig Liver Dis; 2008 Mar; 40(3):156-60. PubMed ID: 18096447
[TBL] [Abstract][Full Text] [Related]
8. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
9. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies.
Scarpulla G; Camilleri S; Galante P; Manganaro M; Fox M
Am J Gastroenterol; 2007 Dec; 102(12):2642-7. PubMed ID: 17850412
[TBL] [Abstract][Full Text] [Related]
10. Use and utility of the Bravo pH capsule.
Pandolfino JE; Kwiatek MA
J Clin Gastroenterol; 2008; 42(5):571-8. PubMed ID: 18364590
[TBL] [Abstract][Full Text] [Related]
11. Bravo capsule placement in the gastric cardia: a novel method for analysis of proximal stomach acid environment.
Pandolfino JE; Schreiner MA; Lee TJ; Zhang Q; Kahrilas PJ
Am J Gastroenterol; 2005 Aug; 100(8):1721-7. PubMed ID: 16086707
[TBL] [Abstract][Full Text] [Related]
12. [Modalities and diagnostic criteria in esophageal ph monitoring].
Bruley des Varannes S; Scarpignato C
Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S21-30. PubMed ID: 10078428
[No Abstract] [Full Text] [Related]
13. The role of pH monitoring in extraesophageal gastroesophageal reflux disease.
Ahmed T; Vaezi MF
Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):319-31. PubMed ID: 15722244
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy, diagnostic utility and tolerance of intraesophageal pH ambulatory determination with wireless pH-testing monitoring system].
Carmona-Sánchez R; Solana-Sentíes S
Rev Gastroenterol Mex; 2004; 69(2):69-75. PubMed ID: 15757154
[TBL] [Abstract][Full Text] [Related]
15. BRAVO wireless 48 hour pH-metric system.
Hess T; Hahn EG; Konturek PC
Med Sci Monit; 2009 Jan; 15(1):RA17-21. PubMed ID: 19114981
[TBL] [Abstract][Full Text] [Related]
16. Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy.
Ayazi S; Lipham JC; Portale G; Peyre CG; Streets CG; Leers JM; Demeester SR; Banki F; Chan LS; Hagen JA; Demeester TR
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):60-7. PubMed ID: 18976965
[TBL] [Abstract][Full Text] [Related]
17. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
18. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
[TBL] [Abstract][Full Text] [Related]
19. Wireless pH monitoring in patients with non-cardiac chest pain.
Prakash C; Clouse RE
Am J Gastroenterol; 2006 Mar; 101(3):446-52. PubMed ID: 16542279
[TBL] [Abstract][Full Text] [Related]
20. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux.
Knight J; Lively MO; Johnston N; Dettmar PW; Koufman JA
Laryngoscope; 2005 Aug; 115(8):1473-8. PubMed ID: 16094128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]